Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Feng Ye
Xiamen University
Xiamen, 361005
China
Contact
Xiamen University
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
136
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Sintilimab Plus Bevacizumab Biosimilar IBI305, and Chemotherapy for Patients with
EGFR
-Mutant Nonsquamous NSCLC Who Progressed on EGFR-TKI Therapy (ORIENT-31): Interim Results from a Randomized, Double-Blind, Phase 3 Study
Number of pages: 38
Posted: 18 Mar 2022
Shun Lu
,
Lin Wu
,
Hong Jian
,
Ying Cheng
,
Qiming Wang
,
Jian Fang
,
Ziping Wang
,
Yanping Hu
,
Meili Sun
,
Liang Han
,
Liyun Miao
,
Cuimin Ding
,
Jiuwei Cui
,
Baolan Li
,
Yueyin Pan
,
Xingya Li
, Feng Ye,
Anwen Liu
,
Ke Wang
,
Shundong Cang
,
Hui Zhou
,
Xing Sun
,
David Ferry
,
Yong Lin
,
Shuyan Wang
,
Wen Zhang
and
Chengli Zhang
Shanghai Jiao Tong University (SJTU) - Shanghai Lung Cancer Center, Zhengzhou University - Henan Provincial People's Hospital, Shanghai Jiao Tong University (SJTU) - Department of Medical Oncology, Jilin Cancer Hospital - Department of Oncology, Zhengzhou University - Henan Cancer Hospital, Peking University - Department of Thoracic Medical Oncology, Peking University - Department of Thoracic Medical Oncology, Huazhong University of Science and Technology - Hubei Cancer Hospital, Shandong First Medical University - Department of Oncology, Xuzhou Central Hospital, Nanjing University - Department of Respiratory Medicine, Hebei Medical University, Jilin University (JLU) - Cancer Center, Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute, University of Science and Technology of China (USTC) - Department of Thoracic Cancer Chemotherapy, Zhengzhou University - Department of Oncology, Xiamen University, Nanjing University, Sichuan University - Department of Respiratory and Critical Care Medicine, Qingdao University - Affiliated Hospital, Innovent Biologics, Inc. - Department of Medical Science and Strategy Oncology, Innovent Biologics, Inc. - Department of Biostatistics and Information, Eli Lilly and Company, Ltd - Department of Oncology Medical Strategy, Eli Lilly and Company, Ltd - Clinical Design, Delivery & Analytics, Innovent Biologics, Inc. - Department of Medical Science and Strategy Oncology, Innovent Biologics, Inc. - Department of Biostatistics and Information and Innovent Biologics, Inc. - Department of Medical Science and Strategy Oncology
Downloads
136
(540,814)
View PDF
Download
Abstract:
sintilimab, IBI305, NSCLC, EGFR
Feedback